Delhi HC allows stem cell treatment to continue until licences under New Drugs and Clinical Rules, 2019 are processedJune 5 2019
In view of the absence of any licenses under the New Drugs and Clinical Rules, 2019 for providing stem cell treatments, the Delhi High Court has allowed a clinic in New Delhi to continue providing a treatment called 'Embryonic Stem Cell therapy' to certain patients until such time a licence is processed under the Rules.
The order was passed by a Division Bench of Justices GS Sistani and Jyoti Singh in petition preferred by two minor children who are patients of Cerebral Palsy.
The Court was informed that the Petitioners visited a clinic ‘Nutech . . .
You need to have an active subscription to view this content.
With a premium account you get:
- One year of unrestrcited access to previous interviews, columns and articles
- One year access to all archival material
- Access to all Bar & Bench reports